China News Service, Beijing, November 26 (Reporter Du Yan) Today, the Beijing Municipal Medical Security Bureau stated that the third batch of nationally organized drug procurement of 55 selected drugs was officially implemented in Beijing, covering hypertension, diabetes, and antipyretics. Commonly used drugs for chronic diseases such as analgesia, digestive system, and respiratory system, as well as some oncology, psychiatric, ophthalmological and other drugs, the winning bid price dropped by an average of 53%, and the maximum drop was more than 95%.
The state organizes centralized drug procurement to adopt the method of quantity procurement, quantity-price linkage, and quantity-for-price. Through competitive bidding, the price of medicines is reduced and the burden of patients' medical expenses is reduced.
According to the Beijing Municipal Medical Security Bureau, since 2019, the state has organized three batches of centralized drug procurement, and Beijing will implement it in March 2019, April 2020, and November 2020.
The third batch of nationally organized drug centralized procurement of 55 selected drugs was officially implemented in Beijing, covering commonly used drugs for chronic diseases such as hypertension, diabetes, antipyretic and analgesic, digestive system, and respiratory system, as well as some drugs for oncology, psychology, and ophthalmology. , The winning bid price dropped by an average of 53%, and the largest drop was more than 95%.
The breast cancer treatment drug Letrozole tablets (2.5mg/tablet), the original price was 9.11 yuan/tablet, after the price reduction, 2.86 yuan/tablet, according to the daily dosage of 1 tablet, the original annual cost per patient was about 3,000 yuan , Now it's down to about 1,000 yuan.
In terms of drug quality, the selected drugs are based on the quality and efficacy consistency evaluation of generic drugs as the standard. The relevant departments will continue to strictly observe the quality of drugs to ensure that the selected drugs are reduced in price and not in quality.
The Beijing Municipal Medical Security Bureau stated that at present, citizens can purchase selected drugs from public medical institutions, military medical institutions, and voluntary medical insurance designated social medical institutions in the city.
At the same time, the centralized purchase of drugs only reduces the price of drugs. When patients use the selected drugs, the reimbursement ratio of drugs remains unchanged.
It is expected that the implementation of the third batch of nationally organized centralized procurement of selected drugs will save the city about 1 billion yuan in procurement costs each year. In the future, centralized drug procurement will continue to be implemented to further reduce the burden on people's medical expenses and improve people's livelihood.